351 related articles for article (PubMed ID: 37121449)
1. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo.
Wang J; Ren C; Bi W; Batu W
J Ethnopharmacol; 2023 Mar; 303():115948. PubMed ID: 36423713
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
5. Xuanbai Chengqi Decoction alleviates acute lung injury by inhibiting NLRP3 inflammasome.
Wang S; Lin F; Zhang C; Gao D; Qi Z; Wu S; Wang W; Li X; Pan L; Xu Y; Tan B; Yang A
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117227. PubMed ID: 37751794
[TBL] [Abstract][Full Text] [Related]
6. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
7. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of total glucosides of White Paeony Capsules in ameliorating acute lung injury based on NLRP3 inflammasome].
Xu YJ; Wang XL; Mu WQ; Wen JC; Wang Y; Xiu Y; Dong X; Li JJ; Zhan XY; Xiao XH; Bai ZF
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2754-2765. PubMed ID: 38812176
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism for regulating lung immune homeostasis: Zukamu granules alleviated acute lung injury in mice by inhibiting NLRP3 inflammasome activation and regulating Th17/Treg cytokine balance.
Yu C; Li Y; Li Y; Li S; Zeng F; Yu J; Ji Z; Li K; Zhai H
J Ethnopharmacol; 2024 Apr; 324():117831. PubMed ID: 38280662
[TBL] [Abstract][Full Text] [Related]
10. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
11. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
12. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
13. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z
Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability.
Li T; Zhang C; Wei Y; Zhong H; Shan L; Yu P; Wang Y; Xu L
Curr Pharm Des; 2022; 28(30):2508-2517. PubMed ID: 35909279
[TBL] [Abstract][Full Text] [Related]
15. YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice.
Wang Y; Wang Y; Ma J; Li Y; Cao L; Zhu T; Hu H; Liu H
J Ethnopharmacol; 2023 Aug; 312():116452. PubMed ID: 37019161
[TBL] [Abstract][Full Text] [Related]
16. Exocarpium Citri Grandis ameliorates LPS-induced acute lung injury by suppressing inflammation, NLRP3 inflammasome, and ferroptosis.
Xu Z; Li J; Zhou K; Wang K; Hu H; Hu Y; Gao Y; Luo Z; Huang J
J Ethnopharmacol; 2024 Jul; 329():118162. PubMed ID: 38588989
[TBL] [Abstract][Full Text] [Related]
17. Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo.
Liu Y; Shang L; Zhou J; Pan G; Zhou F; Yang S
Inflammation; 2022 Apr; 45(2):753-767. PubMed ID: 34787801
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
19. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
[TBL] [Abstract][Full Text] [Related]
20. 6-Gingerol attenuates sepsis-induced acute lung injury by suppressing NLRP3 inflammasome through Nrf2 activation.
Pan Q; Liu P; Wan M
Folia Histochem Cytobiol; 2023; 61(1):68-80. PubMed ID: 36734635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
